Understanding the increased susceptibility to asthma development in preterm infants

Jeremy Anderson1,2, Lien Anh Ha Do1,2, Danielle Wurzel1,3,4

  • 1Infection and Immunity, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.

Allergy
|January 31, 2023
PubMed

Insights

Preterm birth increases asthma risk due to altered immune responses to infections and microbiome changes, not allergies. Understanding these immunological factors is key to developing new asthma prevention strategies for vulnerable infants.

Area of Science:

  • Neonatal immunology and respiratory health.
  • Pediatric pulmonology and asthma pathogenesis.

Background:

  • Preterm birth is linked to abnormal lung development and higher chronic lung disease risk.
  • Asthma prevalence is significantly higher in preterm infants compared to term-born infants.
  • Existing research on preterm asthma focuses on physiological, environmental, and genetic factors, with limited investigation into immunological underpinnings.

Purpose of the Study:

  • To investigate the immunological factors contributing to increased asthma susceptibility in preterm infants.
  • To explore differences in immune responses to viral infections and microbiome composition between preterm and term infants.
  • To identify non-allergic mechanisms driving asthma development in the preterm population.

Main Methods:

  • Comparative analysis of immunological interactions in preterm versus term infants.
  • Assessment of immune responses to common viral infections like Respiratory Syncytial Virus (RSV) and Human Rhinovirus (HRV).
  • Evaluation of microbiome differences and their impact on immune development.

Main Results:

  • Preterm infants exhibit lower rates of atopy and allergic sensitization.
  • Preterm infants are more prone to severe RSV and HRV infections.
  • Significant alterations in the microbiome are observed in preterm infants compared to term infants.

Conclusions:

  • Non-allergic immunological mechanisms, particularly altered responses to viral infections and microbiome dysbiosis, are likely drivers of asthma in preterm infants.
  • Understanding these immunological differences is crucial for developing targeted interventions.
  • This research highlights a critical need for novel strategies to reduce asthma burden in this vulnerable demographic.

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
502
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
374
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
60.1K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.6K